1. 1087. Evaluation of Risk Factors for Infection among Patients Receiving Ibrutinib. (31st December 2020) Authors: Tham, Kenneth; Prelewicz, Stacy; deHoll, Sara; Stephens, Deborah; Gomez, Carlos A Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study. (February 2020) Authors: Gordon, Max J.; Sitlinger, Andrea; Salous, Tareq; Alqahtani, Hamood; Churnetski, Michael; Rivera, Xavier; Wisniewski, Paul; Cohen, Jonathon; Patel, Krish; Shadman, Mayzar; Choi, Michael; Hill, Brian; Stephens, Deborah; Persky, Daniel; Brander, Danielle; Danilov, Alexey V. Journal: Leukemia research Issue: Volume 89(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Jumping translocations, a novel finding in chronic lymphocytic leukaemia. (19th April 2015) Authors: Miller, Cecelia R.; Stephens, Deborah; Ruppert, Amy S.; Racke, Frederick; McFaddin, Andrew; Breidenbach, Heather; Lin, Huey‐Jen; Waller, Kathy; Bannerman, Tammy; Jones, Jeffrey A.; Woyach, Jennifer A.; Andritsos, Leslie A.; Maddocks, Kami; Zhao, Weiqiang; Lozanski, Gerard; Flynn, Joseph M.; Greve... Journal: British journal of haematology Issue: Volume 170:Number 2(2015:Jul.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗